The Board of Shukra Pharmaceuticals at its meeting held on 11 May 2020 has approved the appointment of Mehul Patel as Chief Financial Officer [KMPJ of the Company.
The Board has also appointed Ashvin Trivedi [DIN: 032L2457) as an additional Non-executive director of the Company. Further, the Board has accepted and taken note of Resignation of Karnik Shah as Chief Executive Officer [CEO) of the Company,
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)